Executive Brief — AI Readiness & Data Infrastructure

77% expect AI within two years. Only 11% have the data foundation.

The gap between AI ambition and data readiness defines pharma R&D today. 63% rank AI as top investment (Pistoia Alliance, 2025), but only 11% of biopharma labs have reached a fully predictive state (Deloitte, 2024). Base models commoditize — proprietary scientific data is the moat. The question is whether your data infrastructure can deliver validated, contextualized, traceable data fast enough for AI to operate on.

Get the Executive Brief Explore the Architecture

AI Readiness — The Numbers

77%

Expect AI Adoption Within 2 Years (Pistoia Alliance, 2024)

63%

Rank AI as Top Investment Priority (Pistoia Alliance, 2025)

11%

Have Reached Fully Predictive State (Deloitte, 2024)

81%

ELN Adoption Rate — Foundation Maturing (Pistoia Alliance, 2024)

80%

Cloud Data Platform Adoption (Pistoia Alliance, 2024)

Trusted by 6 of the 10 largest pharmaceutical companies in the world

And leading biotechs and agrochemical companies

6 of 10

Top-10 Pharma Companies

150+

Vendors

400+

Instrument Models

100+

Analytical Techniques

The AI Readiness Gap

AI Investment Is Accelerating. Data Infrastructure Isn't Keeping Pace.

Siloed Instrument data trapped in proprietary formats — AI models trained on incomplete, context-poor data produce unreliable results in regulated workflows

No Lineage Data without provenance cannot support regulatory AI — 21 CFR Part 11 and EU GMP Annex 11 require complete audit trails from input to decision

Repeated Each AI initiative builds new data pipelines from scratch — no shared foundation, no cumulative data asset, no compounding investment

Skip Risk Jumping to Decide (AI) without Integrate, Contextualize, Analyze ( Context, Intelligence) produces models that cannot be validated or governed

What You Get

Three Deliverables, Custom to Your Data Organization

ICAD Maturity Scoring

Your organization assessed across all principles: Integration, Context, Intelligence, and AI-Enabled Decisions. See exactly where you stand today and which principle investments enable AI capabilities.

AI Readiness Gap Analysis

Mapping your current data assets against AI requirements: data standardization, scientific context preservation, cross-program intelligence coverage, and governance readiness for regulated AI workflows.

Data-to-AI Roadmap

Phased plan from current state to AI-enabled decisions. Each phase shows which data capabilities you gain, which AI use cases they enable, and the expected compounding return on data infrastructure investment.

“This opens up the possibility to spend all your time discussing data insights instead of discussing data issues.”

Data Scientist, Novartis TRD

What the Brief Covers

Custom Analysis for Your AI Data Foundation

Data standardization assessment How much of your instrument data arrives in governed, standardized formats versus proprietary vendor formats requiring manual transformation
Scientific context coverage Which experiments, samples, and methods have preserved lineage and context — the prerequisite for meaningful AI training data
Cross-program intelligence readiness Whether your data infrastructure enables portfolio-scale pattern detection, stability trending, and cross-batch analysis
Regulatory AI governance Gap analysis for deploying AI in 21 CFR Part 11 and EU GMP Annex 11 environments — audit trails, model validation, and human-in-the-loop controls
Proprietary data moat assessment Evaluate which data assets are unique to your organization and cannot be replicated by foundation models — the true competitive advantage in AI

Get the AI Readiness Executive Brief

Custom analysis for your data organization. We assess your maturity across the four principles, identify AI readiness gaps, and deliver a phased roadmap from data foundation to AI-enabled decisions.